Currency converter
^
News Feed
News Search Topics
ОК
Use filter
You can filter your feed,
by choosing only interesting
sections.
Loading

Swiss sports court to hear doping case on Russian titled swimmer Efimova

May 20, 18:28 UTC+3 MOSCOW
Late last month FINA decided against lifting the temporary suspension of Efimova before her case was considered by the FINA Doping Panel
1 pages in this article
Yulia Efimova

Yulia Efimova

© Sergei Fadeichev/TASS

MOSCOW, May 20. /TASS/. A decision in the case of possible doping abuse by Russia’s Olympic medalist in swimming Yulia Efimova will be made by the Court of Arbitration for Sport (CAS) in Lausanne, Vladimir Salnikov, the president of the Russian Swimming Federation (RSW), told TASS on Friday.

The International Swimming Federation (FINA) announced earlier in the month that it would hold hearings into the doping case of the 24-year-old Russian swimmer on May 30, but later decided to send her case directly to the Swiss sports court.

"Her case is not on the agenda of the [May 30 FINA Doping] Panel’s session as it went directly to CAS," Salnikov said in an interview with TASS.

"They have agreed to put all materials in one file and debate the case there [in Lausanne]," Salnikov, who is the four-time Olympic champion in swimming, added.

Late last month FINA decided against lifting the temporary suspension of Efimova before her case was considered by the FINA Doping Panel on May 30. The date of her hearings in CAS is yet to be announced.

Efimova, who is Russia’s 2012 Olympic bronze medalist in swimming, the four-time world champion and many times winner of European tournaments, announced in March that her doping sample taken in February had showed the presence of banned substance meldonium. The swimmer was suspended immediately from all international tournaments.

However, the World Anti-Doping Agency (WADA) announced on April 13 that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.

The drug meldonium (mildronate) was included in the list of preparations banned by WADA from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).

Meldronate is a cardiovascular preparation freely available for purchase at pharmacies across Russia without doctor’s prescription.

Show more
In other media
Реклама
Реклама